These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 16172417
1. Nicorandil promotes myocardial capillary and arteriolar growth in the failing heart of Dahl salt-sensitive hypertensive rats. Xu J, Nagata K, Obata K, Ichihara S, Izawa H, Noda A, Nagasaka T, Iwase M, Naoe T, Murohara T, Yokota M. Hypertension; 2005 Oct; 46(4):719-24. PubMed ID: 16172417 [Abstract] [Full Text] [Related]
2. Nicorandil but not ISDN upregulates endothelial nitric oxide synthase expression, preventing left ventricular remodeling and degradation of cardiac function in Dahl salt-sensitive hypertensive rats with congestive heart failure. Horinaka S, Kobayashi N, Yagi H, Mori Y, Matsuoka H. J Cardiovasc Pharmacol; 2006 May; 47(5):629-35. PubMed ID: 16775500 [Abstract] [Full Text] [Related]
3. Angiotensin-converting enzyme inhibition promotes coronary angiogenesis in the failing heart of Dahl salt-sensitive hypertensive rats. Yazawa H, Miyachi M, Furukawa M, Takahashi K, Takatsu M, Tsuboi K, Ohtake M, Murase T, Hattori T, Kato Y, Murohara T, Nagata K. J Card Fail; 2011 Dec; 17(12):1041-50. PubMed ID: 22123369 [Abstract] [Full Text] [Related]
4. Effects of imidapril on endothelin-1 and ACE gene expression in failing hearts of salt-sensitive hypertensive rats. Kobayashi N, Hara K, Higashi T, Matsuoka H. Am J Hypertens; 2000 Oct; 13(10):1088-96. PubMed ID: 11041163 [Abstract] [Full Text] [Related]
6. Effects of imidapril on NOS expression and myocardial remodelling in failing heart of Dahl salt-sensitive hypertensive rats. Kobayashi N, Higashi T, Hara K, Shirataki H, Matsuoka H. Cardiovasc Res; 1999 Dec; 44(3):518-26. PubMed ID: 10690283 [Abstract] [Full Text] [Related]
7. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats. Kobayashi N, Ohno T, Yoshida K, Fukushima H, Mamada Y, Nomura M, Hirata H, Machida Y, Shinoda M, Suzuki N, Matsuoka H. Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150 [Abstract] [Full Text] [Related]
9. Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats. Yamada T, Nagata K, Cheng XW, Obata K, Saka M, Miyachi M, Naruse K, Nishizawa T, Noda A, Izawa H, Kuzuya M, Okumura K, Murohara T, Yokota M. Eur J Pharmacol; 2009 Aug 01; 615(1-3):163-70. PubMed ID: 19501083 [Abstract] [Full Text] [Related]
10. Effects of TCV-116 on expression of NOS and adrenomedullin in failing heart of Dahl salt-sensitive rats. Kobayashi N, Nishikimi T, Horinaka S, Ishimitsu T, Matsuoka H. Atherosclerosis; 2001 Jun 01; 156(2):255-65. PubMed ID: 11395021 [Abstract] [Full Text] [Related]
12. Basic fibroblast growth factor inhibits ventricular remodeling in Dahl salt-sensitive hypertensive rats. Suzuki T, Akasaka Y, Namiki A, Ito K, Ishikawa Y, Yamazaki J, Ishii T. J Hypertens; 2008 Dec 01; 26(12):2436-44. PubMed ID: 19008723 [Abstract] [Full Text] [Related]
13. Nicorandil protects against lethal ischemic ventricular arrhythmias and up-regulates endothelial nitric oxide synthase expression and sulfonylurea receptor 2 mRNA in conscious rats with acute myocardial infarction. Horinaka S, Kobayashi N, Yabe A, Asakawa H, Yagi H, Mori Y, Tsubokou Y, Yoshida K, Nakano S, Matsuoka H. Cardiovasc Drugs Ther; 2004 Jan 01; 18(1):13-22. PubMed ID: 15115899 [Abstract] [Full Text] [Related]
14. Waon therapy attenuates cardiac hypertrophy and promotes myocardial capillary growth in hypertensive rats: a comparative study with fluvastatin. Ihori H, Nozawa T, Sobajima M, Shida T, Fukui Y, Fujii N, Inoue H. Heart Vessels; 2016 Aug 01; 31(8):1361-9. PubMed ID: 26686369 [Abstract] [Full Text] [Related]
16. Aminoguanidine inhibits mitogen-activated protein kinase and improves cardiac performance and cardiovascular remodeling in failing hearts of salt-sensitive hypertensive rats. Kobayashi N, Horinaka S, Mita S, Yoshida K, Honda T, Kobayashi T, Hara K, Nishikimi T, Matsuoka H. J Hypertens; 2002 Dec 01; 20(12):2475-85. PubMed ID: 12473873 [Abstract] [Full Text] [Related]
17. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure. Yamamoto E, Kataoka K, Shintaku H, Yamashita T, Tokutomi Y, Dong YF, Matsuba S, Ichijo H, Ogawa H, Kim-Mitsuyama S. Arterioscler Thromb Vasc Biol; 2007 Dec 01; 27(12):2569-75. PubMed ID: 17932313 [Abstract] [Full Text] [Related]
18. Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats. Mita S, Kobayashi N, Yoshida K, Nakano S, Matsuoka H. J Hypertens; 2005 Jan 01; 23(1):87-96. PubMed ID: 15643129 [Abstract] [Full Text] [Related]
19. Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure. Fukushima H, Kobayashi N, Takeshima H, Koguchi W, Ishimitsu T. J Cardiovasc Pharmacol; 2010 Jan 01; 55(1):83-8. PubMed ID: 19904215 [Abstract] [Full Text] [Related]
20. Vascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failure. Rengo G, Cannavo A, Liccardo D, Zincarelli C, de Lucia C, Pagano G, Komici K, Parisi V, Scala O, Agresta A, Rapacciuolo A, Perrone Filardi P, Ferrara N, Koch WJ, Trimarco B, Femminella GD, Leosco D. Circ Heart Fail; 2013 Nov 01; 6(6):1259-67. PubMed ID: 24029661 [Abstract] [Full Text] [Related] Page: [Next] [New Search]